Cargando...
Identification of a novel, fast acting GABAergic anti-depressant
Current pharmacotherapies for depression exhibit slow onset, side effects and limited efficacy. Therefore, identification of novel fast-onset antidepressants is desirable. GLO1 is a ubiquitous cellular enzyme responsible for the detoxification of the glycolytic byproduct methylglyoxal (MG). We have...
Guardado en:
| Publicado en: | Mol Psychiatry |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5608625/ https://ncbi.nlm.nih.gov/pubmed/28322281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2017.14 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|